- Home
- AUPH vs EVTC Comparison
AUPH vs EVTC Comparison
Compare AUPH & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | EVTC |
|---|---|---|
| Founded | 1993 | 1988 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 2014 | 2013 |
Fundamental Metrics
Financial Performance| Metric | AUPH | EVTC |
|---|---|---|
| Price | $17.22 | $31.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $18.00 | ★ $35.20 |
| AVG Volume (30 Days) | ★ 734.5K | 414.2K |
| Earning Date | 11-10-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 0.64% |
| EPS Growth | ★ 5075.00 | 27.17 |
| EPS | ★ 0.53 | 0.47 |
| Revenue | $283,055,000.00 | ★ $453,869,000.00 |
| Revenue This Year | $16.68 | $16.93 |
| Revenue Next Year | $17.60 | $8.19 |
| P/E Ratio | ★ $32.60 | $66.11 |
| Revenue Growth | ★ 20.38 | 11.48 |
| 52 Week Low | $12.07 | $21.81 |
| 52 Week High | $19.25 | $34.41 |
Technical Indicators
Market Signals| Indicator | AUPH | EVTC |
|---|---|---|
| Relative Strength Index (RSI) | 59.97 | 54.21 |
| Support Level | $15.61 | $28.92 |
| Resistance Level | $17.80 | $31.79 |
| Average True Range (ATR) | 0.42 | 0.87 |
| MACD | 0.07 | -0.03 |
| Stochastic Oscillator | 75.87 | 33.46 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About EVTC Evertec Inc.
Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.